Inventor
ZHANG JIAJUN
US22 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG JIAJUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ENANTA PHARM INC
14 patentsUS11352363B1Jun 7, 2022
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC13 citations86
US11339170B1May 24, 2022
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC17 citations86
US11319325B1May 3, 2022
Macrocyclic spiropyrrolidine derived antiviral agents
ENANTA PHARM INC14 citations85
US11912714B2Feb 27, 2024
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC6 citations75
US12570663B2Mar 10, 2026
Crystal forms of an anti-sars CoV-2 agent
ENANTA PHARM INC0 citations56
US12398147B2Aug 26, 2025
Macrocyclic spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations52
US11970502B2Apr 30, 2024
Macrocyclic antiviral agents
ENANTA PHARM INC0 citations52
US11760755B2Sep 19, 2023
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations52
US11472808B2Oct 18, 2022
Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
ENANTA PHARM INC0 citations52
US11236111B2Feb 1, 2022
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations52
US12540141B2Feb 3, 2026
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations51
US12479854B2Nov 25, 2025
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations51
US12145942B2Nov 19, 2024
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations51
US12006291B2Jun 11, 2024
Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid
ENANTA PHARM INC0 citations51